Jeffrey Lieberman, M.D.

Psychiatry Columbia University, New York, NY 
"Jeffrey Lieberman"
Mean distance: 106866
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lieberman JA, Michels R. (2016) A Scientific Pioneer of Psychiatry. The American Journal of Psychiatry. 173: 574
Girgis RR, Van Snellenberg JX, Glass A, et al. (2016) A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia. Journal of Psychopharmacology (Oxford, England)
Taylor DL, Tiwari AK, Lieberman JA, et al. (2016) Genetic association analysis of N-methyl-d-aspartate receptor subunit gene GRIN2B and clinical response to clozapine. Human Psychopharmacology
Huang E, Zai CC, Lisoway A, et al. (2016) Catechol-O-methyltransferase Val158Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients: a meta-analysis. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp)
Tiwari AK, Brandl EJ, Zai CC, et al. (2015) Association of orexin receptor polymorphisms with antipsychotic-induced weight gain. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-9
Lieberman JA, Davis RE, Correll CU, et al. (2015) ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial. Biological Psychiatry
Lieberman JA. (2015) Response to Kornfeld. The American Journal of Psychiatry. 172: 911
Brandl EJ, Tiwari AK, Zai CC, et al. (2015) Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample. The Pharmacogenomics Journal
Lee SH, Byrne EM, Hultman CM, et al. (2015) New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. International Journal of Epidemiology
Girgis RR, Xu X, Gil RB, et al. (2015) Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [(11)C]-(+)-PHNO. Schizophrenia Research. 168: 373-6
See more...